Sort by
Refine Your Search
-
Category
-
Country
-
Employer
-
Field
-
, Chemistry, or related areas. Recipient category: The open position is intended for candidates holding a master’s degree who, on the date of their hiring, prove their enrolment in one of the following courses
-
, connected, and informed during your ORISE experience and beyond! Application Deadline 10/16/2026 9:35:33 AM Eastern Time Zone Description *Applications will be reviewed on a rolling-basis. CDC Office and
-
but not limited to, COVID-19 requirements (e.g. facial covering, physical distancing, testing, vaccination). Questions: Please visit our Program Website . After reading, if you have additional questions
-
: The open position is intended for candidates holding a master’s degree who, on the date of their hiring, prove their enrolment in a non-degree course. Requirement for granting the fellowship: The applicants
-
its pipeline of drug candidates, the first of which has entered clinical Phase I/II testing at the MD Anderson Cancer Center in Houston, TX (USA). Eisbach Bio GmbH focuses on pioneering precision
-
. Application Requirements A complete application consists of: Zintellect Profile Educational and Employment History Essay Questions (goals, experiences, and skills relevant to the opportunity) Resume (PDF
-
the following conditions: Scientific Area: Bioinformatics Recipient category: The open position is intended for candidates holding a master’s degree who, on the date of their hiring, prove their enrolment in one
-
the Centers for Medicare and Medicaid Services (CMS) accessed through the CMS Virtual Research Data Center, National Health and Nutrition Examination Survey, National Health Interview Survey, and Medical
-
Environmental, Safety and Health (ES&H) requirements of the hosting facility, including but not limited to, COVID-19 requirements (e.g. facial covering, physical distancing, testing, vaccination). Questions
-
, etc.); test the effect of antagonistic and agonistic antibodies and small molecule inhibitors to modulate NK cell receptors on CD4+CD28null T cells and assess changes in function of this cell subset